QDEL Quidel Corporation Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

QDEL [NASD]

Quidel Corporation

Healthcare | Diagnostics & Research | USA

statements

Index	-	P/E	76.61	EPS (ttm)	2.05	Insider Own	8.80%	Shs Outstand	42.06M	Perf Week	-6.18%
Market Cap	6.30B	Forward P/E	21.10	EPS next Y	7.44	Insider Trans	-5.75%	Shs Float	37.07M	Perf Month	11.12%
Income	88.30M	PEG	10.64	EPS next Q	1.16	Inst Own	89.00%	Short Float	5.69%	Perf Quarter	93.55%
Sales	561.60M	P/S	11.21	EPS this Y	-0.50%	Inst Trans	-2.99%	Short Ratio	2.32	Perf Half Y	131.64%
Book/sh	14.39	P/B	10.90	EPS next Y	3.08%	ROA	9.80%	Target Price	100.33	Perf Year	163.11%
Cash/sh	2.71	P/C	57.87	EPS next 5Y	7.20%	ROE	16.00%	52W Range	52.49 - 210.81	Perf YTD	109.10%
Dividend	-	P/FCF	46.74	EPS past 5Y	59.90%	ROI	15.20%	52W High	-25.58%	Beta	1.10
Dividend %	-	Quick Ratio	1.70	Sales past 5Y	23.80%	Gross Margin	61.40%	52W Low	198.90%	ATR	12.29
Employees	1250	Current Ratio	2.10	Sales Q/Q	18.00%	Oper. Margin	20.00%	RSI (14)	48.70	Volatility	4.53% 7.85%
Optionable	Yes	Debt/Eq	0.02	EPS Q/Q	55.20%	Profit Margin	15.70%	Rel Volume	0.69	Prev Close	159.88
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 06 AMC	Payout	0.00%	Avg Volume	910.76K	Price	156.89
Recom	2.30	SMA20	-9.86%	SMA50	15.59%	SMA200	81.77%	Volume	628,581	Change	-1.87%

May-12-20

Downgrade

JP Morgan

Neutral → Underweight

$120 → $158

Mar-26-20

Downgrade

Barclays

Overweight → Equal Weight

$90

Oct-23-18

Resumed

Raymond James

Strong Buy

$80

Mar-08-18

Upgrade

Raymond James

Outperform → Strong Buy

Jan-22-18

Reiterated

Barclays

Overweight

$50 → $60

Jan-04-18

Upgrade

CL King

Neutral → Buy

Sep-19-17

Upgrade

Piper Jaffray

Neutral → Overweight

Jul-18-17

Upgrade

William Blair

Mkt Perform → Outperform

Jul-18-17

Upgrade

Canaccord Genuity

Hold → Buy

$25 → $42

Apr-25-17

Reiterated

Canaccord Genuity

Hold

$24 → $24.50

Feb-17-17

Initiated

CL King

Neutral

Dec-16-16

Downgrade

Piper Jaffray

Overweight → Neutral

Jun-13-16

Upgrade

Raymond James

Mkt Perform → Outperform

Feb-18-16

Reiterated

Barclays

Overweight

$28 → $22

Feb-09-16

Downgrade

Canaccord Genuity

Buy → Hold

$22 → $18

Jan-08-16

Reiterated

Canaccord Genuity

Buy

$25 → $22

Dec-14-15

Downgrade

Raymond James

Outperform → Mkt Perform

Sep-02-15

Initiated

Barclays

Overweight

$28

Jul-31-13

Reiterated

Canaccord Genuity

Buy

$30 → $35

Mar-03-11

Downgrade

Wedbush

Outperform → Neutral

$14 → $13

Jun-04-20 10:00AM	Are These Medical Stocks Cruising Toward Big Gains? Here's A Bullish Sign Investor's Business Daily
Jun-02-20 12:45PM	Quidel (QDEL) is an Incredible Growth Stock: 3 Reasons Why Zacks
Jun-01-20 02:34PM	Quidel Stock Is Up 130% This Year: Is This Coronavirus Stock Still a Hot Buy? Motley Fool
09:50AM	The Zacks Analyst Blog Highlights: Chegg, Bandwidth, Wayfair, Quidel and Atlas Air Worldwide Zacks
May-29-20 10:34AM	The Zacks Analyst Blog Highlights: Chegg, BJ's Wholesale Club, Atlas Air Worldwide, Sprouts Farmers Market and Quidel Zacks
08:33AM	Quidel (QDEL): Strong Industry, Solid Earnings Estimate Revisions Zacks
07:50AM	5 Top Momentum Stocks for June as U.S. Economy Reopens Zacks
May-28-20 07:53AM	Major Indexes Regain Crucial Milestones: 5 Top Growth Picks Zacks +6.18%
May-27-20 11:12AM	Zacks.com featured highlights include: Eli Lilly and Company, Quidel, Everbridge and Sprouts Farmers Market Zacks
May-26-20 04:10PM	Quidel to Present Virtually at William Blair 40th Annual Growth Stock Conference Business Wire -7.31%
May-23-20 08:00AM	Teladoc, Neurocrine Bio Lead Five Healthy Stocks To Monitor Closely Investor's Business Daily
May-22-20 12:30PM	Quidel Stock Is Finally Correcting: What to Do Now TheStreet.com
09:45AM	How Quidel's New Test Could Be A Game-Changer In Coronavirus Investor's Business Daily
May-20-20 09:07AM	The Zacks Analyst Blog Highlights: Chegg, Quidel, MarketAxess, Dropbox and Vertex Pharmaceuticals Zacks
08:59AM	JPMorgan: 2 Stocks to Snap Up Now (And 1 to Avoid) TipRanks
May-19-20 09:42AM	Can Quidel (QDEL) Run Higher on Strong Earnings Estimate Revisions? Zacks
06:46AM	Major Indexes Defying "Sell in May" Adage: 5 Growth Picks Zacks
May-18-20 08:30PM	Quidels Lyra® Direct SARS-CoV-2 Assay Receives Emergency Use Authorization and CE Mark for Molecular Detection of COVID-19, Without Extraction Step Business Wire -7.34%
09:43AM	Top Ranked Momentum Stocks to Buy for May 18th Zacks
08:44AM	Quidel (QDEL) in Focus: Stock Moves 6.2% Higher Zacks
May-15-20 03:43PM	Healthcare Tech & Robotics ETFs in Focus amid COVID-19 Crisis Zacks +6.21%
11:48AM	Quidel Shares Rise as FDA Probes Abbott's Covid-19 Test TheStreet.com
May-14-20 12:45PM	Looking for a Growth Stock? 3 Reasons Why Quidel (QDEL) is a Solid Choice Zacks
May-13-20 11:30AM	Is Quidel (QDEL) Outperforming Other Medical Stocks This Year? Zacks
03:19AM	Edited Transcript of QDEL earnings conference call or presentation 6-May-20 9:00pm GMT Thomson Reuters StreetEvents
May-12-20 01:54PM	The Zacks Analyst Blog Highlights: Pluralsight, Quidel, Vista Outdoor, SunOpta and Nautilus Zacks -12.65%
01:13PM	The Zacks Analyst Blog Highlights: Wayfair, Chegg, Moderna, Quidel and Clorox Zacks
May-11-20 05:40PM	US Indexes Post Some Gains Monday GuruFocus.com +31.75%
04:46PM	Dow Jones Falls, Quidel Soars 31% As Tech-Heavy Nasdaq Leads Market Rally Investor's Business Daily
04:15PM	Red-Hot Medical Stock Soars To Fresh High On 15-Minute Coronavirus Test Investor's Business Daily
03:24PM	Here's Why Quidel Stock Is Soaring Today Motley Fool
03:09PM	Dow Jones Lags But Nasdaq Rallies On Big Cap Techs, Soaring Coronavirus Stocks Investor's Business Daily
01:46PM	Dow Jones Holds Strong After 600-Point Weekly Gain; Here Are 5 Growth Stocks To Watch Investor's Business Daily
01:05PM	Dow Jones Falls 250 Points, As Post-Coronavirus Stock Market Rally Continues; Covid-19 Tester Soars 31% On FDA News Investor's Business Daily
11:47AM	IBD Live Q&A And Two Key Stock Lists For May 11, 2020 Investor's Business Daily
10:28AM	Quidel Rapid Covid-19 Test Wins Emergency FDA Clearance TheStreet.com
09:59AM	Dow Jones Today, Stocks Ease Amid Mixed Global Trade; FDA Approves Quidel, Tesla Restart Uncertain Investor's Business Daily
09:11AM	Results: Quidel Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts Simply Wall St.
08:40AM	5 Stocks to Buy as America Prepares to Reopen Economy Zacks
07:38AM	An Outstanding Week for Market Amid Record Job Losses: 5 Picks Zacks
06:40AM	Quidel's Recently Approved Antigen Test For Coronavirus Is 'Game Changer,' Former FDA Chief Says Benzinga
May-10-20 12:13PM	New Coronavirus Antigen Test Earns Emergency Authorization from FDA Motley Fool
04:09AM	Quidels Rapid Covid-19 Antigen Test Scores Emergency FDA Approval SmarterAnalyst
May-09-20 04:58PM	U.S. Cases Up 2.1%; Travelers to U.K. Must Isolate: Virus Update Bloomberg
10:53AM	U.S. FDA grants emergency use authorization to Quidel for first antigen test for COVID-19 Reuters
May-08-20 09:00PM	Quidel Receives Emergency Authorization for Rapid Antigen COVID-19 Diagnostic Assay Business Wire
May-07-20 02:31AM	Quidel (QDEL) Q1 2020 Earnings Call Transcript Motley Fool +7.85%
May-06-20 08:05PM	Quidel (QDEL) Beats Q1 Earnings and Revenue Estimates Zacks
04:10PM	Quidel Reports First Quarter 2020 Financial Results Business Wire
May-05-20 11:02AM	Why Quidel Stock Soared 42% in April Motley Fool
10:19AM	What's in the Cards for Quidel (QDEL) This Earnings Season? Zacks
08:36AM	Trump Pushes for US-Made Medical Products: 4 Winners Zacks
May-04-20 03:17PM	On Quidel, Time to Book Profits and Take a Victory Lap TheStreet.com
Apr-30-20 08:29AM	Here's What Quidel Corporation's (NASDAQ:QDEL) P/E Is Telling Us Simply Wall St.
Apr-29-20 05:00PM	Quidel to Present Virtually at the BofA Securities 2020 Health Care Conference Business Wire
12:34PM	Quidel (QDEL) Earnings Expected to Grow: Should You Buy? Zacks
Apr-24-20 04:01PM	Dow Faces Key Test In Coronavirus Rebound; 5 IBD 50 Stocks Surge 10% Or More In 1 Week Investor's Business Daily +7.62%
Apr-22-20 05:00PM	Quidels Lyra® Direct SARS-CoV-2 Assay Submitted for Emergency Use Authorization for Molecular Detection of COVID-19, Without Extraction Step Business Wire +9.54%
Apr-21-20 04:10PM	Quidel to Hold First Quarter 2020 Financial Results Conference Call on May 6th, 2020 Business Wire
Apr-14-20 12:45PM	Quidel (QDEL) is an Incredible Growth Stock: 3 Reasons Why Zacks
Apr-05-20 04:29PM	Do Hedge Funds Love Quidel Corporation (QDEL)? Insider Monkey
Mar-31-20 06:06AM	Here's What Quidel Corporation's (NASDAQ:QDEL) ROCE Can Tell Us Simply Wall St. -5.63%
Mar-26-20 08:23AM	The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Xencor Licenses Tech To Vir For COVID-19 Treatment, Delay In Pfizer's Upjohn-Mylan Merger Benzinga +10.26%
Mar-25-20 08:45PM	Quidels Lyra® SARS-CoV-2 Assay Receives Authorization for Expanded Use for Molecular Detection of COVID-19; Also Receives CE Mark, Health Canada Authorization Business Wire -5.86%
Mar-24-20 02:30PM	Quidel Soared in Recent Months but More Upside Remains TheStreet.com
07:43AM	The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics Zacks
06:51AM	Three stocks that are part of the solution to the coronavirus crisis MarketWatch
Mar-18-20 01:01PM	IBD 50 Stocks To Watch: Diagnostics Leader Quidel Wins Emergency FDA Authorization For Coronavirus Testing Investor's Business Daily
Mar-17-20 08:30PM	Quidel Receives Emergency Use Authorization for Molecular COVID-19 Diagnostic Assay Business Wire +26.20%
Mar-16-20 11:03AM	Sectors That Can Prosper During the Pandemic Investopedia -6.28%
Mar-12-20 11:27AM	Quidel (QDEL) Looks Good: Stock Adds 10.8% in Session Zacks -9.31%
Mar-08-20 10:08AM	Is Quidel (NASDAQ:QDEL) Using Too Much Debt? Simply Wall St.
Feb-19-20 10:52PM	Edited Transcript of QDEL earnings conference call or presentation 12-Feb-20 10:00pm GMT Thomson Reuters StreetEvents
Feb-18-20 04:10PM	Quidel to Present at Upcoming Conferences Business Wire
Feb-17-20 07:54AM	Quidel Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next Simply Wall St.
Feb-12-20 06:45PM	Quidel (QDEL) Q4 Earnings and Revenues Surpass Estimates Zacks
04:10PM	Quidel Reports Fourth Quarter and Full Year 2019 Financial Results Business Wire
Feb-05-20 12:30PM	Earnings Preview: Quidel (QDEL) Q4 Earnings Expected to Decline Zacks
Jan-28-20 04:10PM	Quidel to Hold Fourth Quarter and Full Year 2019 Financial Results Conference Call on February 12th, 2020 Business Wire
12:46PM	Is Quidel Corporation's (NASDAQ:QDEL) ROE Of 14% Impressive? Simply Wall St.
Jan-09-20 06:00PM	Quidel Announces Preliminary Revenue for Fourth Quarter 2019 Business Wire
12:41PM	What Does Quidel Corporation's (NASDAQ:QDEL) Share Price Indicate? Simply Wall St.
Dec-13-19 11:04AM	Quidel Corporation (QDEL): Hedge Funds In Wait-and-See Mode Insider Monkey
Dec-11-19 12:34PM	Here's Why We Think Quidel (NASDAQ:QDEL) Is Well Worth Watching Simply Wall St.
Nov-19-19 11:18AM	Here's How P/E Ratios Can Help Us Understand Quidel Corporation (NASDAQ:QDEL) Simply Wall St.
Nov-14-19 06:00PM	Quidel to Present at Upcoming Conferences Business Wire
Nov-05-19 09:40AM	Edited Transcript of QDEL earnings conference call or presentation 30-Oct-19 9:00pm GMT Thomson Reuters StreetEvents
Oct-30-19 08:35PM	Quidel (QDEL) Surpasses Q3 Earnings and Revenue Estimates Zacks
04:10PM	Quidel Reports Third Quarter 2019 Financial Results Business Wire
11:43AM	How Does Quidel Corporation (NASDAQ:QDEL) Affect Your Portfolio Volatility? Simply Wall St.
Oct-24-19 02:06PM	Heres What Hedge Funds Think About Quidel Corporation (QDEL) Insider Monkey
Oct-23-19 10:33AM	Quidel (QDEL) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Oct-17-19 06:00PM	Quidel to Hold Third Quarter 2019 Financial Results Conference Call on October 30th, 2019 Business Wire
Oct-10-19 12:02PM	Should You Be Worried About Insider Transactions At Quidel Corporation (NASDAQ:QDEL)? Simply Wall St.
Sep-23-19 11:28AM	We Think Quidel (NASDAQ:QDEL) Can Stay On Top Of Its Debt Simply Wall St.
Sep-06-19 12:19AM	Edited Transcript of QDEL earnings conference call or presentation 8-Aug-19 9:00pm GMT Thomson Reuters StreetEvents
Sep-04-19 12:25PM	Are Quidel Corporations (NASDAQ:QDEL) High Returns Really That Great? Simply Wall St.
Aug-30-19 09:15PM	Quidel Corp (QDEL) President & CEO Douglas C Bryant Sold $4.5 million of Shares GuruFocus.com
Aug-19-19 08:02AM	Investors Who Bought Quidel (NASDAQ:QDEL) Shares Three Years Ago Are Now Up 190% Simply Wall St.
Aug-12-19 12:48PM	Edited Transcript of QDEL earnings conference call or presentation 6-Nov-18 10:00pm GMT Thomson Reuters StreetEvents

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a point-of-care products for the detection of infectious and inflammatory diseases and conditions of the eye. The company also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the determination of the presence of drug and/or the major metabolites in urine. In addition, the company offers traditional cell lines, specimen collection devices, media, and controls for use in laboratories that culture and test for various human viruses, including respiratory and herpes family viruses; and cell-based products comprising tubes, shell vials, and multi-well plates. Further, it provides biomarkers, which include clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation; and enzyme linked immunosorbent assays and reagents for the detection of activation products. Additionally, it offers AmpliVue hand-held molecular diagnostic assay platform for the detection of the pathogen; Solana, an amplification and detection system; and Lyra molecular real-time polymerase chain reaction assays. The company markets its products through distributors and direct sales force for use in physician offices, hospitals, clinical laboratories, reference laboratories, leading universities, retail and urgent care clinics, pharmacies, and wellness screening centers. Quidel Corporation was founded in 1979 and is headquartered in San Diego, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kroll Werner	SVP, R&D	May 27	Option Exercise	0.00	4,376	0	8,975	May 27 07:54 PM
Kroll Werner	SVP, R&D	May 22	Option Exercise	20.46	68,152	1,394,422	72,751	May 27 07:54 PM
Kroll Werner	SVP, R&D	May 22	Sale	174.44	68,152	11,888,149	4,599	May 27 07:54 PM
Bujarski Robert Joseph	SVP, NA Comm Ops & Gen Counsel	May 20	Sale	189.41	20,000	3,788,282	13,383	May 22 07:59 PM
Abney Michael Donald Jr.	SVP - Distribution	May 18	Option Exercise	17.95	15,970	286,675	15,432	May 20 08:02 PM
BORKAR RATAN S	SVP, Intl Comm Operations	May 18	Option Exercise	31.88	16,332	520,699	27,171	May 20 08:07 PM
STEWARD RANDALL J	Chief Financial Officer	May 18	Sale	185.35	20,000	3,707,040	2,848	May 20 08:11 PM
BORKAR RATAN S	SVP, Intl Comm Operations	May 18	Sale	192.82	28,312	5,459,113	524	May 20 08:07 PM
Abney Michael Donald Jr.	SVP - Distribution	May 18	Sale	198.46	15,970	3,169,387	6,634	May 20 08:02 PM
SLACIK CHARLES P	Director	May 15	Option Exercise	0.00	549	0	11,352	May 18 08:16 PM
BUECHLER KENNETH F	Director	May 15	Option Exercise	0.00	1,842	0	59,824	May 18 08:06 PM
WIDDER KENNETH J	Director	May 14	Option Exercise	0.00	2,100	0	14,416	May 18 08:21 PM
Strobeck Matthew	Director	May 14	Option Exercise	0.00	2,100	0	7,399	May 18 08:19 PM
BUECHLER KENNETH F	Director	May 14	Option Exercise	0.00	2,100	0	57,982	May 18 08:06 PM
SLACIK CHARLES P	Director	May 14	Option Exercise	0.00	2,100	0	10,803	May 18 08:16 PM
SCHULER JACK W	Director	May 14	Option Exercise	0.00	2,100	0	3,103,249	May 18 08:14 PM
POLAN MARY LAKE PH D	Director	May 14	Option Exercise	0.00	2,100	0	22,884	May 18 08:12 PM
ORDONEZ KATHY	Director	May 14	Option Exercise	0.00	1,856	0	1,856	May 18 08:10 PM
Michael Edward L.	Director	May 14	Option Exercise	0.00	2,100	0	2,934	May 18 08:08 PM
POLAN MARY LAKE PH D	Director	May 11	Sale	204.27	6,700	1,368,630	20,784	May 12 08:01 PM
BUECHLER KENNETH F	Director	May 11	Sale	200.00	5,000	1,000,000	55,882	May 13 08:01 PM
BUECHLER KENNETH F	Director	May 05	Option Exercise	13.25	10,449	138,449	60,882	May 07 08:05 PM
Russell Edward Keith	SVP, Business Development	Feb 26	Option Exercise	15.40	12,601	194,055	29,791	Feb 28 08:03 PM
Russell Edward Keith	SVP, Business Development	Feb 26	Sale	79.58	12,601	1,002,796	17,190	Feb 28 08:03 PM
POLAN MARY LAKE PH D	Director	Jan 07	Option Exercise	21.07	9,041	190,494	28,584	Jan 09 08:23 PM
BORKAR RATAN S	SVP, Intl Comm Operations	Dec 06	Option Exercise	15.67	11,122	174,226	20,426	Dec 09 07:59 PM
BORKAR RATAN S	SVP, Intl Comm Operations	Dec 06	Sale	70.00	11,122	778,540	9,304	Dec 09 07:59 PM
BORKAR RATAN S	SVP, Intl Comm Operations	Dec 05	Option Exercise	23.41	4,700	110,027	14,004	Dec 09 07:59 PM
BORKAR RATAN S	SVP, Intl Comm Operations	Dec 05	Sale	70.00	4,700	329,000	9,304	Dec 09 07:59 PM
Kroll Werner	SVP, R&D	Dec 03	Option Exercise	22.85	6,620	151,267	23,389	Dec 05 09:35 PM
Kroll Werner	SVP, R&D	Dec 03	Sale	68.02	22,951	1,561,078	3,795	Dec 05 09:35 PM
Russell Edward Keith	SVP, Business Development	Nov 26	Option Exercise	19.56	15,974	312,438	32,452	Nov 27 07:47 PM
Russell Edward Keith	SVP, Business Development	Nov 26	Sale	68.73	15,974	1,097,951	16,478	Nov 27 07:47 PM
BORKAR RATAN S	SVP, Intl Comm Operations	Nov 26	Sale	68.40	6,621	452,885	9,304	Nov 27 07:45 PM
BORKAR RATAN S	SVP, Intl Comm Operations	Nov 25	Sale	69.18	332	22,969	15,925	Nov 27 07:45 PM
BRYANT DOUGLAS C	President & CEO	Nov 20	Option Exercise	22.42	377,744	8,470,451	679,186	Nov 22 08:03 PM
STEWARD RANDALL J	Chief Financial Officer	Sep 23	Option Exercise	15.40	29,328	451,651	48,787	Sep 25 07:59 PM
STEWARD RANDALL J	Chief Financial Officer	Sep 23	Sale	62.60	29,328	1,836,041	19,459	Sep 25 07:59 PM
GIBSON KAREN	SVP, IS & Bus. Transformation	Sep 13	Sale	67515.00	4,527	305,640,405	759	Sep 13 08:01 PM
BORKAR RATAN S	SVP, Intl Comm Operations	Sep 11	Option Exercise	27.34	5,575	152,421	21,768	Sep 13 07:58 PM
BUECHLER KENNETH F	Director	Sep 11	Option Exercise	13.25	4,000	53,000	54,433	Sep 13 07:59 PM
GIBSON KAREN	SVP, IS & Bus. Transformation	Sep 11	Option Exercise	25.55	14,354	366,745	19,545	Sep 13 08:01 PM
GIBSON KAREN	SVP, IS & Bus. Transformation	Sep 11	Sale	68.61	14,354	984,880	5,191	Sep 13 08:01 PM
BUECHLER KENNETH F	Director	Sep 11	Sale	68.86	4,000	275,421	50,433	Sep 13 07:59 PM
BORKAR RATAN S	SVP, Intl Comm Operations	Sep 11	Sale	70.00	5,575	390,250	16,257	Sep 13 07:58 PM
Abney Michael Donald Jr.	SVP - Distribution	Sep 10	Option Exercise	15.40	8,798	135,489	14,226	Sep 12 08:01 PM
Abney Michael Donald Jr.	SVP - Distribution	Sep 10	Sale	65.00	8,798	571,870	5,790	Sep 12 08:01 PM
BRYANT DOUGLAS C	President & CEO	Aug 30	Option Exercise	15.19	510	7,747	301,952	Aug 30 08:00 PM
BRYANT DOUGLAS C	President & CEO	Aug 30	Sale	65.40	510	33,354	301,442	Aug 30 08:00 PM
BRYANT DOUGLAS C	President & CEO	Aug 29	Option Exercise	15.19	45,948	697,950	347,390	Aug 30 08:00 PM
BRYANT DOUGLAS C	President & CEO	Aug 29	Sale	64.28	45,948	2,953,400	301,442	Aug 30 08:00 PM
BRYANT DOUGLAS C	President & CEO	Aug 28	Option Exercise	15.19	25,250	383,548	326,692	Aug 30 08:00 PM
BRYANT DOUGLAS C	President & CEO	Aug 28	Sale	58.30	25,250	1,472,075	301,442	Aug 30 08:00 PM
BRYANT DOUGLAS C	President & CEO	Jul 29	Option Exercise	15.19	21,789	330,975	323,231	Jul 31 08:04 PM
BRYANT DOUGLAS C	President & CEO	Jul 29	Sale	57.78	21,789	1,258,968	301,442	Jul 31 08:04 PM
BRYANT DOUGLAS C	President & CEO	Jun 28	Option Exercise	15.19	3,461	52,573	304,903	Jun 28 07:59 PM
BRYANT DOUGLAS C	President & CEO	Jun 26	Option Exercise	14.60	25,250	368,602	326,692	Jun 28 07:59 PM
BRYANT DOUGLAS C	President & CEO	Jun 26	Sale	57.25	25,250	1,445,613	301,442	Jun 28 07:59 PM
Russell Edward Keith	S.V.P., N.A. Commercial Ops	Jun 18	Option Exercise	17.38	13,000	225,905	22,598	Jun 20 07:54 PM
Russell Edward Keith	S.V.P., N.A. Commercial Ops	Jun 18	Sale	57.16	13,000	743,046	9,598	Jun 20 07:54 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience